Cannabis and Drug Interactions: Peer-Reviewed Research Consensus
Overview
The research base for cannabis and drug interactions includes 160 peer-reviewed studies spanning 1976–2026. Of these, 18 provide strong evidence, including 4 meta-analyses and 14 randomized controlled trials. Key findings with strong support include: meta-analysis of pivotal trials found cbd has independent anti-seizure effects, though the benefit is amplified by interaction with clobazam, and a meta-analysis of 4 rcts confirmed cbd significantly reduces seizures both with and without clobazam, though the effect was somewhat larger with clobazam. However, several findings remain debated, and the evidence is not uniform across all areas. Many studies have methodological limitations including small sample sizes, short follow-up periods, and reliance on self-reported data.
What the Research Shows
Findings supported by multiple peer-reviewed studies. Stronger evidence means more consistency across study types.
Meta-analysis of pivotal trials found CBD has independent anti-seizure effects, though the benefit is amplified by interaction with clobazam
Strong EvidenceA meta-analysis of 4 RCTs confirmed CBD significantly reduces seizures both with and without clobazam, though the effect was somewhat larger with clobazam
Strong EvidenceMeta-analysis of 4 RCTs (714 patients) showed CBD reduced seizures in Dravet and Lennox-Gastaut syndrome regardless of whether patients were also taking clobazam
Strong EvidenceWhere Scientists Disagree
Areas where research shows conflicting results or ongoing scientific debate.
Double-blind crossover study of 24 volunteers found CBD partially inhibits THC liver metabolism, though the effect was small relative to natural variation, and women achieved significantly higher THC blood levels than men
Moderate EvidenceYear-long study found combined MDMA and cannabis users had sustained immune cell decreases and more infections, with cannabis-only users showing intermediate effects
Moderate EvidenceYear-long study found ecstasy polydrug users showed mild cognitive decline while cannabis was paradoxically linked to faster brain processing speed on EEG measures
Moderate EvidenceA review described how chronic nicotine and alcohol each alter cannabinoid receptors, endocannabinoid content, and multiple other brain systems, reducing each other's withdrawal and increasing preference for combined use
Moderate EvidenceWhat We Still Don't Know
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Evidence Breakdown
Distribution of study types in this research area. Higher-tier evidence (meta-analyses, RCTs) provides stronger conclusions.
Key Studies
The most impactful research in this area.
CBD reduced seizures in both Dravet and Lennox-Gastaut syndromes, with enhanced effects when combined with clobazam
This meta-analysis directly addresses the critical question of whether CBD's seizure reduction is partly driven by its interaction with clobazam, showing CBD is effective in both clobazam users and the overall population, but more so in the combination.
CBD does have independent anti-seizure effects, though clobazam interaction boosts them
This addresses the critical question of whether CBD is truly anti-epileptic or merely boosting clobazam levels, concluding that both mechanisms contribute.
Meta-analysis of 4 RCTs confirms CBD reduces seizures with and without clobazam co-treatment
A persistent question has been whether CBD's seizure benefit depends on its interaction with clobazam rather than direct anticonvulsant effects. This meta-analysis demonstrates independent efficacy.
CBD works for seizures whether or not patients also take clobazam
A key debate in epilepsy medicine was whether CBD works on its own or only because it boosts clobazam blood levels through a drug interaction. This analysis suggests CBD has independent anti-seizure efficacy.
Phase 1 trial maps CBD drug interactions with three common epilepsy medications
These three AEDs are among the most commonly co-prescribed with CBD for Lennox-Gastaut and Dravet syndromes. Knowing that CBD triples the active clobazam metabolite is clinically actionable: clobazam doses may need reduction when adding CBD.
How Long Cannabis Shows Up in Urine — and Why Current Thresholds May Be Wrong
Urine testing is the most common form of cannabis detection in workplaces, criminal justice, and sport — affecting millions of people. This systematic review demonstrates that current thresholds often detect past use rather than recent consumption or impairment. For regular users trying to quit, wee
Research Timeline
How our understanding of this topic has evolved.
Pre-2000
3 studies published. Includes 2 RCTs.
2000–2009
7 studies published. Includes 1 RCTs.
2010–2014
19 studies published. Predominantly observational and review studies.
2015–2019
43 studies published. Includes 4 RCTs, 5 strong-evidence studies.
2020–present
88 studies published. Includes 4 meta-analyses, 7 RCTs, 13 strong-evidence studies.
About This Consensus
This consensus synthesizes 160 peer-reviewed studies: 4 meta-analyses (3%), 14 randomized controlled trials (9%), 28 observational studies (18%), 48 reviews (30%), 4 case studies (3%), 62 other study types (39%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
This page synthesizes findings from 160 peer-reviewed studies. It is not medical advice. Always consult a healthcare provider for personal health decisions.